I interviewed Kintor: GT20029 Clinical Trial Pictures. As well as KX826.
    Research/Science 12/25/2024

    At a glance
    In this research discussion post, the primary subjects mentioned are
    💧 GT20029 (topical) 1% 2x weekly
    💧 KX826 (topical) 0.5% 52 weeks
    the tone is 😀 positive with promising results.

    Other terms

    GT20029 and KX826 are promising hair loss treatments, with GT20029 increasing hair count and KX826 showing significant results. KX826 may be a good alternative for those who can't use finasteride or dutasteride, though results vary.
    View this post in the Community →

    Similar Community Posts Join

    5 / 233 results

      community Is GT20029 supposed to regrow hair as well?

      in Treatment  10 upvotes 1 year ago
      The user is considering switching from finasteride to dutasteride for hair loss. They are unsure if GT20029 can regrow hair, particularly on the temples. Another user mentions that regrowth on finasteride can take up to 2 years.

      community Wtf have we been doing for the last 30 years

      in Treatment  547 upvotes 2 weeks ago
      Hair loss treatments like finasteride, minoxidil, and dutasteride work but have side effects. A permanent cure is still not available due to the complexity of hair loss and limited investment.

      community Kintor Phase 2 Results released KX-826 (pyrilutamide)

      in Research/Science  448 upvotes 2 years ago
      Kintor Pharmaceutical's Phase 2 results with the drug Pyrilutamide, a potential alternative to 5-ARI drugs like Finasteride and Dutasteride but without the side effects. It could be used in combination with other topical treatments such as Minoxidil. The safety of the drug has been demonstrated in 6 months of use, however there are still questions about long term efficacy and systemic absorption.

    Related Research

    5 / 5 results